Journal of Clinical Endocrinology & Metabolism, Vol 72, 1268-1277, Copyright © 1991 by Endocrine Society

ARTICLES

Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation

H Yki-Jarvinen, I Puhakainen and VA Koivisto
Second Department of Medicine, University of Helsinki, Finland.

We tested whether FFAs influence glucose uptake by human peripheral tissues in vivo. Whole body glucose uptake, FFA turnover, energy expenditure and substrate oxidation rates, forearm glucose and FFA uptake, and nonoxidative glycolysis (net release of alanine and lactate) were measured in 14 normal male subjects in the basal state (0- 240 min; serum insulin, approximately 5 microU/mL) and during euglycemic hyperinsulinemia (240-360 min; approximately 75 microU/mL) on 2 separate occasions, once during elevation of plasma FFA by infusions of Intralipid and heparin (plasma FFA, 4.6 +/- 0.1 vs. 4.2 +/- 0.4 mmol/L; 180-240 vs. 300-360 min) and once during infusion of saline (plasma FFA, 0.50 +/- 0.07 vs. 0.02 +/- 0.07 mmol/L, respectively). In the basal state, whole body glucose disposal remained unchanged, but the fate of glucose was significantly altered toward diminished oxidation (7.3 +/- 0.8 vs. 5.6 +/- 0.5 mumol/kg.min; P less than 0.05, saline vs. Intralipid) and increased nonoxidative glycolysis (P less than 0.05). Elevation of plasma FFA significantly increased forearm glucose uptake (1.0 +/- 0.6 vs. 2.4 +/- 0.7 mumol/kg.min; P less than 0.01) and nonoxidative glycolysis (net release of alanine and lactate, 0.4 +/- 0.5 vs. 1.2 +/- 0.4 mumol glucose equivalents/kg.min; P less than 0.05). During hyperinsulinemia, FFA decreased whole body glucose disposal (38 +/- 2 vs. 30 +/- 3 mumol/kg.min; P less than 0.001) due to a decrease in glucose oxidation (13 +/- 1 vs. 7 +/- 1 mumol/kg.min; P less than 0.01, saline vs. Intralipid), and forearm glucose uptake (31 +/- 4 vs. 24 +/- 6 mumol/kg.min; P less than 0.01, saline vs. Intralipid). Under these conditions, 7 +/- 2% and 3 +/- 1% (P less than 0.05) of forearm glucose uptake could be accounted for by nonoxidative glycolysis in the Intralipid and saline studies, respectively. In summary, 1) elevation of plasma FFA concentrations suppresses the rate of carbohydrate oxidation to a rate that, both basally and during hyperinsulinemia, is similar to that reported for insulin-independent glucose oxidation in the brain; 2) basally, forearm glucose uptake is increased by FFA; and 3) during hyperinsulinemia, FFA inhibit glucose uptake by forearm tissues. We conclude that the interaction between glucose and FFA fuels in human forearm tissues is dependent upon the ambient insulin concentration; the increase in basal glucose uptake would be compatible with the increase need of glucose for FFA reesterification; the decrease in insulin-stimulated glucose uptake supports operation of the glucose-FFA cycle in human forearm tissues.

This article has been cited by other articles:

				K. Chokkalingam, K. Jewell, L. Norton, J. Littlewood, L. J. C. van Loon, P. Mansell, I. A. Macdonald, and K. Tsintzas High-Fat/Low-Carbohydrate Diet Reduces Insulin-Stimulated Carbohydrate Oxidation but Stimulates Nonoxidative Glucose Disposal in Humans: An Important Role for Skeletal Muscle Pyruvate Dehydrogenase Kinase 4 J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 284 - 292. [Abstract] [Full Text] [PDF]

				S. B Haugaard, O. Andersen, F. Dela, J. J. Holst, H. Storgaard, M. Fenger, J. Iversen, and S. Madsbad Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic {beta}-cells Eur. J. Endocrinol., January 1, 2005; 152(1): 103 - 112. [Abstract] [Full Text] [PDF]

				V. Qvisth, E. Hagstrom-Toft, S. Enoksson, R. S. Sherwin, S. Sjoberg, and J. Bolinder Combined Hyperinsulinemia and Hyperglycemia, But Not Hyperinsulinemia Alone, Suppress Human Skeletal Muscle Lipolytic Activity in Vivo J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4693 - 4700. [Abstract] [Full Text] [PDF]

				S. R. Kashyap, R. Belfort, R. Berria, S. Suraamornkul, T. Pratipranawatr, J. Finlayson, A. Barrentine, M. Bajaj, L. Mandarino, R. DeFronzo, et al. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E537 - E546. [Abstract] [Full Text] [PDF]

				H. Norrelund, C. Djurhuus, J. O. L. Jorgensen, S. Nielsen, K. S. Nair, O. Schmitz, J. S. Christiansen, and N. Moller Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E737 - E743. [Abstract] [Full Text] [PDF]

				E.-J. Freyse, T. Giessmann, K. J. Petzke, S. Knospe, G. Engel, P. Heinke, C. C. Metges, and W. Siegmund Effects of fatty acids on hepatic amino acid catabolism and fibrinogen synthesis in young healthy volunteers Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E54 - E62. [Abstract] [Full Text] [PDF]

				C. J. Homko, P. Cheung, and G. Boden Effects of Free Fatty Acids on Glucose Uptake and Utilization in Healthy Women Diabetes, February 1, 2003; 52(2): 487 - 491. [Abstract] [Full Text] [PDF]

				E. Moberg, S. Sjoberg, E. Hagstrom-Toft, and J. Bolinder No apparent suppression by insulin of in vivo skeletal muscle lipolysis in nonobese women Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E295 - E301. [Abstract] [Full Text] [PDF]

				S. Nielsen, N. Moller, S. B. Pedersen, J. S. Christiansen, and J. O. L. Jorgensen The Effect of Long-Term Pharmacological Antilipolysis on Substrate Metabolism in Growth Hormone (GH)-Substituted GH-Deficient Adults J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3274 - 3278. [Abstract] [Full Text] [PDF]

				G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]

				M. J Roef, K. de Meer, D.-J. Reijngoud, H. W. Straver, M. de Barse, S. C Kalhan, and R. Berger Triacylglycerol infusion does not improve hyperlactemia in resting patients with mitochondrial myopathy due to complex I deficiency Am. J. Clinical Nutrition, February 1, 2002; 75(2): 228 - 236. [Abstract] [Full Text] [PDF]

				J. M. Abadie, G. T. Malcom, J. R. Porter, and F. Svec Dehydroepiandrosterone Alters Zucker Rat Soleus and Cardiac Muscle Lipid Profiles Experimental Biology and Medicine, September 1, 2001; 226(8): 782 - 789. [Abstract] [Full Text] [PDF]

				G. Perseghin, P. Scifo, E. Pagliato, A. Battezzati, S. Benedini, L. Soldini, G. Testolin, A. Del Maschio, and L. Luzi Gender Factors Affect Fatty Acids-Induced Insulin Resistance in Nonobese Humans: Effects of Oral Steroidal Contraception J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3188 - 3196. [Abstract] [Full Text] [PDF]

				J. P. Frias, G. B. Macaraeg, J. Ofrecio, J. G. Yu, J. M. Olefsky, and Y. T. Kruszynska Decreased Susceptibility to Fatty Acid-Induced Peripheral Tissue Insulin Resistance in Women Diabetes, June 1, 2001; 50(6): 1344 - 1350. [Abstract] [Full Text]

				M. Krebs, M. Krssak, P. Nowotny, D. Weghuber, S. Gruber, V. Mlynarik, M. Bischof, H. Stingl, C. Fürnsinn, W. Waldhäusl, et al. Free Fatty Acids Inhibit the Glucose-Stimulated Increase of Intramuscular Glucose-6-Phosphate Concentration in Humans J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2153 - 2160. [Abstract] [Full Text]

				M. Krebs, H. Stingl, P. Nowotny, D. Weghuber, M. Bischof, W. Waldhausl, and M. Roden Prevention of in Vitro Lipolysis by Tetrahydrolipstatin Clin. Chem., July 1, 2000; 46(7): 950 - 954. [Abstract] [Full Text] [PDF]

				T. Utriainen, S. Lovisatti, S. Makimattila, A. Bertoldo, S. Weintraub, R. DeFronzo, C. Cobelli, and H. Yki-Jarvinen Direct measurement of the lumped constant for 2-deoxy-[1-14C]glucose in vivo in human skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E228 - E233. [Abstract] [Full Text] [PDF]

				F. Fery, L. Plat, and E. O. Balasse Effect of fasting on the intracellular metabolic partition of intravenously infused glucose in humans Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E815 - E823. [Abstract] [Full Text] [PDF]

				P. M. Piatti, L. D. Monti, A. Caumo, M. Conti, F. Magni, M. Galli-Kienle, E. Fochesato, A. Pizzini, L. Baldi, G. Valsecchi, et al. Mediation of the Hepatic Effects of Growth Hormone by Its Lipolytic Activity J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1658 - 1663. [Abstract] [Full Text]

				L. S. Sidossis, B. Mittendorfer, D. Chinkes, E. Walser, and R. R. Wolfe Effect of hyperglycemia-hyperinsulinemia on whole body and regional fatty acid metabolism Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E427 - E434. [Abstract] [Full Text] [PDF]

				J.-Y. Park, C.-H. Kim, S. K. Hong, K. I. Suh, and K.-U. Lee Effects of FFA on insulin-stimulated glucose fluxes and muscle glycogen synthase activity in rats Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E338 - E344. [Abstract] [Full Text] [PDF]

				F. Fery, L. Plat, M. Baleriaux, and E. O. Balasse Inhibition of Lipolysis Stimulates Whole Body Glucose Production and Disposal in Normal Postabsorptive Subjects J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 825 - 830. [Abstract] [Full Text] [PDF]